FDA recall D-0299-2022

Product

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Reason for recall

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Distribution

Nationwide in the USA

Key facts

Status

Terminated

Initiation date

2021-12-03

Report date

2022-01-05

Termination date

2022-07-25

Voluntary/Mandated

Voluntary: Firm initiated

Location

Foster City, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0299-2022